Menu Search
Equities

BRAIN Biotech AG

BNNn:DEU

BRAIN Biotech AG

Actions
  • Price (EUR)2.79
  • Today's Change0.03 / 1.09%
  • Shares traded9.62k
  • 1 Year change-50.71%
  • Beta--
Data delayed at least 15 minutes, as of May 02 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BRAIN Biotech AG, formerly known as BRAIN Biotechnology Research and Information Network AG is a Germany-based industrial biotechnology company develops and brings to market biological ingredients for Nutrition & Health, SkinCare and Industrial BioSolutions. Research & Development activities focus on bioactive natural compounds, tailored enzymes and high-performance microorganisms.

  • Revenue in EUR (TTM)55.23m
  • Net income in EUR-8.40m
  • Incorporated2000
  • Employees311.00
  • Location
    BRAIN Biotech AGDarmstaedter Strasse 34-36ZWINGENBERG 64673GermanyDEU
  • Phone+49 625193310
  • Fax+49 6 251933111
  • Websitehttps://www.brain-biotech.de/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		BNNX.N:GER since
announced		Transaction
value
Biocatalysts LtdAnnounced24 May 202324 May 2023Announced-44.86%--
Data delayed at least 15 minutes, as of May 03 2024 15:10 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.